(Q54518446)

30 May 2018

title

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. (English)

1 reference

30 May 2018

12

Borhane Slama

1 reference

30 May 2018

author name string

Mandy Brecqueville

1

1 reference

30 May 2018

Jérôme Rey

2

1 reference

30 May 2018

François Bertucci

3

1 reference

30 May 2018

Emilie Coppin

4

1 reference

30 May 2018

Pascal Finetti

5

1 reference

30 May 2018

Nadine Carbuccia

6

1 reference

30 May 2018

Nathalie Cervera

7

1 reference

30 May 2018

Véronique Gelsi-Boyer

8

1 reference

30 May 2018

Christine Arnoulet

9

1 reference

30 May 2018

Olivier Gisserot

10

1 reference

30 May 2018

Denis Verrot

11

1 reference

30 May 2018

Norbert Vey

13

1 reference

30 May 2018

Marie-Joelle Mozziconacci

14

1 reference

30 May 2018

Daniel Birnbaum

15

1 reference

30 May 2018

Anne Murati

16

1 reference

30 May 2018

publication date

9 April 2012

1 reference

30 May 2018

Genes, Chromosomes and Cancer

published in

1 reference

30 May 2018

volume

51

1 reference

30 May 2018

issue

8

1 reference

30 May 2018

page(s)

743-755

1 reference

30 May 2018

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

cites work

1 reference

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

21 January 2018

1 reference

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

21 January 2018

1 reference

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes.

21 January 2018

1 reference

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms

21 January 2018

1 reference

Mutations of ASXL1 gene in myeloproliferative neoplasms.

21 January 2018

1 reference

Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.

21 January 2018

1 reference

Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor

21 January 2018

1 reference

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

Molecular aspects of myeloproliferative neoplasms.

21 January 2018

1 reference

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

21 January 2018

1 reference

Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family

21 January 2018

1 reference

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

21 January 2018

1 reference

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

21 January 2018

1 reference

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

21 January 2018

1 reference

TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms

21 January 2018

1 reference

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

21 January 2018

1 reference

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases

21 January 2018

1 reference

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

21 January 2018

1 reference

Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications

21 January 2018

1 reference

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

21 January 2018

1 reference

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

21 January 2018

1 reference

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

21 January 2018

1 reference

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

ASXL1 mutations in primary and secondary myelofibrosis.

21 January 2018

1 reference

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

21 January 2018

1 reference

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.

21 January 2018

1 reference

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.

21 January 2018

1 reference

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

21 January 2018

1 reference

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

21 January 2018

1 reference

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

21 January 2018

1 reference

Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

21 January 2018

1 reference

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

Myelodysplastic syndromes: lost between two states?

21 January 2018

1 reference

7 January 2021

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

1 reference

7 January 2021

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

1 reference

7 January 2021

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

1 reference

7 January 2021

Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases

1 reference

7 January 2021

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

1 reference

7 January 2021

DNMT3A mutations in myeloproliferative neoplasms

1 reference

7 January 2021

Mutation in TET2 in myeloid cancers

1 reference

7 January 2021

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.21960

1 reference

30 May 2018

PubMed ID

22489043

1 reference

30 May 2018